Company Profile
Updated: 11-NOV-09Novartis Inc.
International public company
Lichtstrasse 35, Basel, CH-4002, Switzerland
()41 41 613241111, 41 (41)613248001 fax, http://www.novartis.com/
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Pharmaceutical preparations and supplies, generic drugs and supplies, animal vaccines, medications and supplies, agricultural chemicals, contact lenses and related supplies, ophthalmic surgical products, and health, baby food and formula products. Finance: Holding company for manufacturers of pharmaceutical preparations and supplies, generic drugs and supplies, animal vaccines, medications and supplies, agricultural chemicals, contact lenses and related supplies, ophthalmic surgical products, and health, baby food and formula products. More
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Alnylam Pharmaceuticals Reports Third Quarter 2009 Financial Results.(Financial report)
Blood Weekly; 11/19/2009; 2211 words; ...Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY...Alnylam Pharmaceuticals, Inc.). "Activities this...five research term in our Novartis alliance. Indeed, Alnylam...amortization revenues from Novartis, the National Institutes...Cubist Pharmaceuticals, Inc., Biogen Idec Inc...
Pharmaceutical Industry in Sweden - Includes Data on Market Size and Segmentation, Key Trends and Competitive Landscape, Leading Companies & Much More.
Biotech Week; 11/18/2009; 1243 words; ...Industry Forecast E. Competition in the Industry F. Leading Players in the Market F.1 AstraZeneca Plc F.2 Pfizer Inc F.3 Novartis AG G. Appendix G.1 Offshoring in the Pharmaceutical Sector G.2.1 Offshoring of R&D G.3.1 Offshoring...
Studies from C.S. Osborne and co-researchers update current data on pneumonia.(Report)
Biotech Week; 11/18/2009; 1525 words; ...Chemotherapy, 2009;53(9):3777-3781). For additional information, contact C.S. Osborne, Novartis Institute BioMed Research Inc., Room 8654, 100 Technology Sq, Cambridge, MA 02139, USA. The publisher of the journal Antimicrobial...
The Global Sourcing Forum + Expo Puts the Spotlight on CIOs, CFOs and COOs with Two Special Roundtables.
Biotech Week; 11/18/2009; 834 words; ...Gerard Insall, CIO of Avis Budget Group Inc. leads this discussion that will feature...of IT Global Governance & Operations at Novartis; PK Agarwal, CTO of the State of California...Investing, Investment, Technology, Novartis AG, Pharmaceutical Business, Pharmaceutical...
ARIAD's AP24534 Featured in Cancer Cell Publication as a Potential First-in-Class Pan BCR-ABL Inhibitor.
Cancer Weekly; 11/17/2009; 1410 words; ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) announced...collaboration with Merck & Co., Inc. ARIAD's second product candidate...are registered trademarks of Novartis AG, and Sprycel[R] is a...of Bristol-Myers Squibb, Inc. Keywords: , Health, Biotechnology...
Novartis AG is the world's fourth largest pharmaceutical firm, earning annual revenues exceeding $23 billion. The company produces and distributes numerous drugs, healthcare operations, contact lenses and medications under various labels. The company also provides agribusiness services and crop seeds to various agriculture businesses. The company's top competitors include companies such as Johnson and Johnson and Merck. Daniel Vasella runs the company.
Recent News Articles
- Zacks Analyst Blog Highlights: Infinity Pharmaceuticals Inc, Novartis, Pfizer, OmniVision Technologies Inc and Google.(Clinical report)
Business Wire - April 17, 2009 - Voltaren Gel.(NEW FORMULATIONS)(Novartis Consumer Health Inc.'s drug gets FDA approval )(Brief article)
Drug Topics - November 19, 2007 - Novartis Animal Health US Inc.: new 75-mg dose for NSAID.(SMALL ANIMAL)
Veterinary Economics - November 01, 2007 - Three Days In September: Generic Famvir[R] Temporarily Delayed On The Launch Pad.(Novartis Pharmaceuticals Corp.)(Teva Pharmaceuticals USA Inc.)
Mondaq Business Briefing - September 28, 2007
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
